Related references
Note: Only part of the references are listed.Tafenoquine: a toxicity overview
Cindy S. Chu et al.
EXPERT OPINION ON DRUG SAFETY (2021)
The epidemiology and detectability of asymptomatic plasmodium vivax and plasmodium falciparum infections in low, moderate and high transmission settings in Ethiopia
Elifaged Hailemeskel et al.
MALARIA JOURNAL (2021)
Safety of Weekly Primaquine in Glucose 6 Phosphatase Dehydrogenase (G6PD) Deficient Children
Salma Shaikh et al.
JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL (2021)
The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
Saber Dini et al.
BMC MEDICINE (2020)
Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
Robert J. Commons et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Robert J. Commons et al.
BMC MEDICINE (2019)
8-Aminoquinoline Therapy for Latent Malaria
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2019)
The glucose-6-phosphate dehydrogenase Mahidol variant protects against uncomplicated Plasmodium vivax infection and reduces disease severity in a Kachin population from northeast Myanmar
Haoan Yi et al.
INFECTION GENETICS AND EVOLUTION (2019)
The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
Phaik Yeong Cheah et al.
BMC MEDICAL ETHICS (2018)
Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity
Mohammad Shafiul Alam et al.
PLOS ONE (2018)
Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group
Kamala Thriemer et al.
MALARIA JOURNAL (2017)
Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens
Tesfay Abreha et al.
BMC INFECTIOUS DISEASES (2015)
Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
Sim Kheng et al.
BMC MEDICINE (2015)
Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo
Adeshina I. Adekunle et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia
Nicholas M. Douglas et al.
BMC MEDICINE (2014)
G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests
Gonzalo J. Domingo et al.
MALARIA JOURNAL (2013)
Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in south and south-east Iran, 2008-2011
A. Miahipour et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2013)
Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
Nicholas M. Douglas et al.
PLOS MEDICINE (2013)
Relapses Contribute Significantly to the Risk of Plasmodium vivax Infection and Disease in Papua New Guinean Children 1-5 Years of Age
Inoni Betuela et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Determinants of relapse periodicity in Plasmodium vivax malaria
Nicholas J. White
MALARIA JOURNAL (2011)
Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
Saorin Kim et al.
PLOS ONE (2011)
Positively Selected G6PD-Mahidol Mutation Reduces Plasmodium vivax Density in Southeast Asians
Chalisa Louicharoen et al.
SCIENCE (2009)
A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan
Toby Leslie et al.
PLOS ONE (2008)
Plasmodium vivax and mixed infections are associated with severe malaria in children:: A prospective cohort study from Papua New Guinea
Blaise Genton et al.
PLOS MEDICINE (2008)
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development
Ernest Beutler et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
The assessment of antimalarial drug efficacy
NJ White
TRENDS IN PARASITOLOGY (2002)
Share Paper
